{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:49:54Z","timestamp":1782442194295,"version":"3.54.5"},"reference-count":27,"publisher":"Duke University Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The COVID-19 pandemic is just one of two public health crises the new Biden administration will confront. The addiction crisis is the other. The opioid epidemic has already killed more Americans than World Wars I and II combined. And it is but the most visible sign of a broader population health challenge that includes methamphetamine, cocaine, benzodiazepines, and alcohol. This article presents practical legislative and executive actions that are required for addressing these challenges. The authors focus on two broad policy challenges: (1) improving financing and delivery of treatment for substance use disorders, and (2) reducing population exposure to addictive and lethal substances. Through both of these channels, a portfolio of well-implemented, evidence-informed policies can save many thousands of lives every year.<\/jats:p>","DOI":"10.1215\/03616878-8970796","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T02:28:54Z","timestamp":1611628134000},"page":"585-597","source":"Crossref","is-referenced-by-count":9,"title":["Policy Responses to the Addiction Crisis"],"prefix":"10.1215","volume":"46","author":[{"given":"Richard G.","family":"Frank","sequence":"first","affiliation":[{"name":"Harvard University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith N.","family":"Humphreys","sequence":"additional","affiliation":[{"name":"Stanford University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold A.","family":"Pollack","sequence":"additional","affiliation":[{"name":"University of Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"73","reference":[{"key":"2021072015045844100_jhppl8970796C1","unstructured":"AlpertAbby E., EvansWilliam N., LieberEthan M. J., and PowellDavid. 2019. \u201cOrigins of the Opioid Crisis and Its Enduring Impacts.\u201d National Bureau of Economic Research, NBER Working Paper 26500, November. www.nber.org\/system\/files\/working_papers\/w26500\/w26500.pdf."},{"key":"2021072015045844100_jhppl8970796C2","unstructured":"AMA (American Medical Association). 2020. \u201cIssue Brief: Reports of Increases in Opioid- and Other Drug-Related Overdose and Other Concerns during COVID Pandemic.\u201d September 1. www.ama-assn.org\/system\/files\/2020-11\/issue-brief-increases-in-opioid-related-overdose.pdf."},{"issue":"8","key":"2021072015045844100_jhppl8970796C3","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2020.8969","article-title":"Therapies Offered at Residential Addiction Treatment Programs in the United States","volume":"324","author":"Beetham","year":"2020","journal-title":"JAMA"},{"key":"2021072015045844100_jhppl8970796C4","unstructured":"Biden-Harris. 2020. \u201cThe Biden Plan to End the Opioid Crisis.\u201d Joe Biden for President: Official Campaign Website. joebiden.com\/opioidcrisis\/ (accessed February 18, 2021)."},{"key":"2021072015045844100_jhppl8970796C5","unstructured":"CEA (Council of Economic Advisers). 2017. \u201cThe Underestimated Cost of the Opioid Crisis.\u201d November 22. www.hsdl.org\/?search=&searchfield=&all=the+underestimated+cost+of+the+opioid+crisis&collection=public&submitted=Search."},{"key":"2021072015045844100_jhppl8970796C6","unstructured":"ChristieChris, BakerCharlie, CooperRoy, KennedyPatrick J., MadrasBertha, and BondiPam. 2017. \u201cThe President's Commission on Combating Drug Addiction and the Opioid Crisis.\u201d November 1. houstonrecoverycenter.org\/wp-content\/uploads\/2019\/01\/Presidents-Commission-Final-Report.pdf."},{"key":"2021072015045844100_jhppl8970796C7","volume-title":"Paying the Tab: The Costs and Benefits of Alcohol Control.","author":"Cook","year":"2007"},{"issue":"5","key":"2021072015045844100_jhppl8970796C8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jamainternmed.2017.0147","article-title":"Addressing the Opioid Epidemic in the United States: Lessons from the Department of Veterans Affairs","volume":"177","author":"Gellad","year":"2017","journal-title":"JAMA Internal Medicine"},{"key":"2021072015045844100_jhppl8970796C9","unstructured":"GoplerudEric. 2013. \u201cConsistency of Large Employer and Group Health Plan Benefits with Requirements of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008.\u201d Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, November 1. aspe.hhs.gov\/report\/consistency-large-employer-and-group-health-plan-benefits-requirements-paul-wellstone-and-pete-domenici-mental-health-parity-and-addiction-equity-act-2008."},{"issue":"6","key":"2021072015045844100_jhppl8970796C10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/jamainternmed.2018.1999","article-title":"Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians with Subsequent Opioid Prescribing","volume":"178","author":"Hadland","year":"2018","journal-title":"JAMA Internal Medicine"},{"issue":"2","key":"2021072015045844100_jhppl8970796C11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1176\/appi.ps.201400575","article-title":"Health Plans' Early Response to Federal Parity Legislation for Mental Health and Addiction Services","volume":"67","author":"Horgan","year":"2016","journal-title":"Psychiatry Services"},{"issue":"3","key":"2021072015045844100_jhppl8970796C12","first-page":"118","article-title":"Opioids of the Masses: Stopping an American Epidemic from Going Global","volume":"97","author":"Humphreys","year":"2018","journal-title":"Foreign Affairs"},{"key":"2021072015045844100_jhppl8970796C13","volume-title":"Crisis Standards of Care: Summary of a Workshop Series","author":"IOM (Institute of Medicine) Forum on Medical and Public Health Preparedness for Catastrophic Events","year":"2010"},{"key":"2021072015045844100_jhppl8970796C14","unstructured":"JalalHawre, and BurkeDonald S.. 2020. \u201cCarfentanil and the Rise and Fall of Overdose Deaths in the United States.\u201d Addiction, September 15. doi.org\/10.1111\/add.15260."},{"issue":"12","key":"2021072015045844100_jhppl8970796C15","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1377\/hlthaff.2017.0890","article-title":"Only One in Twenty Justice-Referred Adults in Specialty Treatment for Opioid Use Receive Methadone or Buprenorphine","volume":"36","author":"Krawczyk","year":"2017","journal-title":"Health Affairs"},{"issue":"8","key":"2021072015045844100_jhppl8970796C16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our Other Prescription Drug Problem","volume":"378","author":"Lembke","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"2021072015045844100_jhppl8970796C17","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1377\/hlthaff.2015.1668","article-title":"Risk-Adjustment Simulation: Plans May Have Incentives to Distort Mental Health and Substance Use Coverage","volume":"35","author":"Montz","year":"2016","journal-title":"Health Affairs"},{"key":"2021072015045844100_jhppl8970796C18","unstructured":"NIH (National Institutes of Health). 2019. \u201cNational Pain Strategy: A Comprehensive Population Health-Level Strategy for Pain.\u201d Homeland Security Digital Library. www.hsdl.org\/?view&did=792119 (accessed February 18, 2021)."},{"issue":"35","key":"2021072015045844100_jhppl8970796C19","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6935a1","article-title":"Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants\u2014Twenty-Four States and the District of Columbia, January\u2013June 2019","volume":"69","author":"O'Donnell","year":"2020","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"2021072015045844100_jhppl8970796C20","volume-title":"Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health","author":"SAMHSA (Substance Abuse and Mental Health Services Administration)","year":"2016"},{"key":"2021072015045844100_jhppl8970796C21","volume-title":"Facing Addiction in America: The Surgeon General's Spotlight on Opioids","author":"SAMHSA (Substance Abuse and Mental Health Services Administration)","year":"2018"},{"key":"2021072015045844100_jhppl8970796C22","unstructured":"ShoverChelsea L., FalasinnuTitlola O., DwyerCandice L., Benitez SantosNayelie, CunninghamNicole J., FreedmanRohan B., VestNoel A., and HumphreysKeith. 2020. \u201cSteep Increases in Fentanyl-Related Mortality West of the Mississippi River: Recent Evidence from County and State Surveillance.\u201d Drug and Alcohol Dependence, November 1. doi.org\/10.1016\/j.drugalcdep.2020.108314."},{"issue":"2","key":"2021072015045844100_jhppl8970796C23","doi-asserted-by":"crossref","first-page":"e1921451","DOI":"10.1001\/jamanetworkopen.2019.21451","article-title":"Trends in Alcohol-Induced Deaths in the United States, 2000\u20132016","volume":"3","author":"Spillane","year":"2020","journal-title":"JAMA Network Open"},{"issue":"7396","key":"2021072015045844100_jhppl8970796C24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/bmj.326.7396.959","article-title":"Loss of Tolerance and Overdose Mortality after Inpatient Opiate Detoxification: Follow Up Study","volume":"236","author":"Strang","year":"2003","journal-title":"British Medical Journal"},{"key":"2021072015045844100_jhppl8970796C25","unstructured":"US Department of Labor. 2016. \u201cImproving Health Coverage for Mental Health and Substance Use Disorder Patients.\u201d Report to Congress, January. www.dol.gov\/Sites\/Dolgov\/Files\/EBSA\/Laws-and-Regulations\/Laws\/Mental-Health-Parity\/Improving-Health-Coverage-for-Mental-Health-and-Substance-Use-Disorder-Patients.pdf."},{"key":"2021072015045844100_jhppl8970796C26","unstructured":"US GAO (US Government Accountability Office). 2018. \u201cIllicit Opioids: While Greater Attention Given to Combating Synthetic Opioids, Agencies Need to Better Assess Their Efforts.\u201d March 29. www.gao.gov\/products\/GAO-18-205."},{"key":"2021072015045844100_jhppl8970796C27","volume-title":"Slaying the Dragon","author":"White","year":"2014","edition":"2nd"}],"container-title":["Journal of Health Politics, Policy and Law"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/read.dukeupress.edu\/jhppl\/article-pdf\/46\/4\/585\/930004\/585frank.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/read.dukeupress.edu\/jhppl\/article-pdf\/46\/4\/585\/930004\/585frank.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T10:04:49Z","timestamp":1670925889000},"score":1,"resource":{"primary":{"URL":"https:\/\/read.dukeupress.edu\/jhppl\/article\/46\/4\/585\/167872\/Policy-Responses-to-the-Addiction-Crisis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1215\/03616878-8970796","relation":{},"ISSN":["0361-6878","1527-1927"],"issn-type":[{"value":"0361-6878","type":"print"},{"value":"1527-1927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}